BioSpace News Archive

Kala Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology

CI’s patented MRO™ (Multiple Reference OCT) technology aims to power affordable personal devices to safely monitor disease progression

A new study published in Obstetrics and Gynecology shows the method of cycle-tracking based on cycle length alone via apps cannot accurately predict ovulation for couples trying to conceive.

Seasoned Scientist Brings R&D & Entrepreneurial Expertise to Innovative Company

They’ve already reached $12,000 on WeFunder!

riple-S Management Corporation (NYSE: GTS) today announced that it plans to release financial results for the third quarter ended September 30, 2018

BAN2401 is a selective anti-amyloid beta (Aβ) protofibril antibody.

NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of OPKO Health, Inc. from September 26, 2013 through September 7, 2018, inclusive (the “Class Period”) of the important November 13, 2018 lead plaintiff deadline in the first filed case commenced by the Rosen Firm. The lawsuit seeks to recover damages for OPKO investors under the federal securities laws.

LISTERINE® fresh breath - no sink required.